Regulus Therapeutics - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

AdvoCare’s Spark Chamoy Mango launch shows how wellness brands are chasing bolder cravings

AdvoCare just gave Spark a spicy twist, but will limited-time flavor drops keep consumers hooked?

Representative image of SAP headquarters in Walldorf, Germany, as the European Commission investigates ERP maintenance policies

SAP (NYSE: SAP) bets €1bn on Prior Labs and Dremio as enterprise AI strategy widens

Adani Ports breaks out at record Rs 1,747 as 500 MMT milestone meets Hormuz reroute trade (NSE: ADANIPORTS)

Newark landing scare: United Airlines jet strikes bakery truck before safe touchdown

Novartis headquarters building showcasing its global pharmaceutical leadership and expansion in renal disease treatments through the Regulus Therapeutics acquisition.

Read More

Pharma Industry News

Novartis to acquire Regulus Therapeutics in $1.7bn deal to advance farabursen for ADPKD treatment

Novartis to acquire Regulus Therapeutics for $1.7 billion, gaining next-gen kidney drug farabursen for ADPKD. Read the market reaction and deal insights.

byPallavi Madhiraju

May 2, 2025

web analytics